Analytics

Equity Analytics

Equity Analytics/PEN

PEN

Penumbra, Inc.

Healthcare - US

Penumbra, Inc. (NYSE: PEN) is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices for neurovascular and peripheral vascular interventions; thrombectomy systems including the Penumbra Syst…

HQ: Alameda, CA, United States of Americawww.penumbrainc.com

USD320.91+0.04%vs prev. close

Performance

+0.53%

+0.25%

-1.87%

+15.13%

YTD

+3.22%

Valuation

P/E

80.8

EPS TTM

3.97

Dividend yield

—

Size and risk

Market cap

$12.6B

Beta

0.69

Next earnings

Report date

EPS estimate

Revenue estimate

Peer comparison

Penumbra
PEN
Medical Devices
Mkt cap (USD bn)
12.6
P/E
80.8
Div yld
—
1W
+0.5%
1M
+0.3%
3M
-1.9%
6M
-0.4%
1Y
+15.1%
YTD
+3.2%

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Penumbra	PEN	Medical Devices	12.6	80.8	—	+0.5%	+0.3%	-1.9%	-0.4%	+15.1%	+3.2%

Subscribe to Equity Analytics to compare PEN with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

Ask, then keep asking: it follows the conversation for 30 minutes, grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.

Equity Analytics

PEN

Price history

Next earnings

Peer comparison

Equity Analytics

PEN

Price history

Next earnings

Peer comparison